CLINICAL_TRIALS ClinicalTrials.gov record update

HM2014-26 DT2219 Immunotoxin for the Treatment of Relapsed or Refractory CD19 (+) and/or CD 22 (+) B-lineage Leukemia or Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02370160
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:26.814222+00:00
Published At: 2020-01-13T00:00:00+00:00
Record Updated At: 2020-01-13
Results Posted At: 2020-01-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Refractory B-Lineage Leukemia", "Relapsed B-Lineage Leukemia", "Refractory B-Lineage Lymphoma", "Relapsed B-Lineage Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-01-13"
protocolSection.identificationModule.nctId: "NCT02370160"
protocolSection.identificationModule.officialTitle: "HM2014-26 DT2219 Immunotoxin for the Treatment of Relapsed or Refractory CD19 (+) and/or CD 22 (+) B-lineage Leukemia or Lymphoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-01-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.